How Federal Regulatory Strategies Are Spurring Innovation in the Use of AI in Cancer Care

5 Key Takeaways

• 1

  The FDA's guidance on predetermined change control plans (PCCPs) for AI devices enhances safety and effectiveness in oncology care.

• 2

  PCCPs allow manufacturers to manage algorithm drift without needing new FDA reviews for each AI model iteration.

• 3

  Augmented reality systems are being developed to assist surgeons in tumor resections, aiming to improve surgical outcomes.

• 4

  AI integration in cancer care is crucial for clinical decision support, but requires careful regulation to avoid bias.

• 5

  Efforts are underway to bridge the gap in AI utilization between National Cancer Institute-designated centers and community cancer centers.